Patents by Inventor Cheryl L. Miller

Cheryl L. Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating lower urinary tract disorders
    Patent number: 7115606
    Abstract: The invention relates to a method of treating at least one symptom of a lower urinary tract disorder in a subject in need of treatment wherein the symptom is selected from the group consisting of urinary frequency, urinary urgency, urinary urge incontinence, nocturia and enuresis. The method comprises administering to a subject in need of treatment a therapeutically effective amount of a compound that has 5-HT3 receptor antagonist activity and NorAdrenaline Reuptake Inhibitor (NARI) activity.
    Type: Grant
    Filed: June 7, 2004
    Date of Patent: October 3, 2006
    Assignee: Dynogen Pharmaceuticals, Inc.
    Inventors: Steven B. Landau, Cheryl L. Miller, Matthew O. Fraser
  • Method of treating nausea, vomiting, retching or any combination thereof
    Patent number: 7094786
    Abstract: Methods are disclosed for the treatment of nausea and vomiting in a patient suffering therefrom comprising administering 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine.
    Type: Grant
    Filed: May 14, 2004
    Date of Patent: August 22, 2006
    Assignee: Dynogen Pharmaceuticals, Inc.
    Inventors: Steven B. Landau, Cheryl L. Miller, Karl B. Thor
  • Method of treating lower urinary tract disorders
    Patent number: 6846823
    Abstract: The invention relates to a method of treating at least one symptom of a lower urinary tract disorder in a subject in need of treatment wherein the symptom is selected from the group consisting of urinary frequency, urinary urgency, urinary urge incontinence, nocturia and enuresis. The method comprises administering to a subject in need of treatment a therapeutically effective amount of a compound that has 5-HT3 receptor antagonist activity and NorAdrenaline Reuptake Inhibitor (NARI) activity.
    Type: Grant
    Filed: April 2, 2004
    Date of Patent: January 25, 2005
    Assignee: Dynogen Pharmaceuticals, Inc.
    Inventors: Steven B. Landau, Cheryl L. Miller, Matthew O. Fraser
  • Method of treating nausea, vomiting, retching or any combination thereof
    Publication number: 20040254171
    Abstract: The invention relates to a method of treating nausea, vomiting, retching or any combination thereof in a subject in need of treatment. The method comprises administering to a subject in need of treatment a therapeutically effective amount of a compound that has 5-HT3 receptor antagonist activity and NorAdrenaline Reuptake Inhibitor (NARI) activity. The invention further relates to a method of treating nausea, vomiting, retching or any combination thereof in a subject in need thereof, comprising coadministering to said subject a first amount of a 5-HT3 antagonist and a second amount of a NARI, wherein the first and second amounts together comprise a therapeutically effective amount or are each present in a therapeutically effective amount. In addition, the method of the invention comprises administering a NARI alone.
    Type: Application
    Filed: May 14, 2004
    Publication date: December 16, 2004
    Applicant: Dynogen, Inc.
    Inventors: Steven B. Landau, Cheryl L. Miller, Karl B. Thor
  • Method of treating nausea, vomiting, retching or any combination thereof
    Publication number: 20040254172
    Abstract: The invention relates to a method of treating nausea, vomiting, retching or any combination thereof in a subject in need of treatment. The method comprises administering to a subject in need of treatment a therapeutically effective amount of a compound that has 5-HT3 receptor antagonist activity and NorAdrenaline Reuptake Inhibitor (NARI) activity. The invention further relates to a method of treating nausea, vomiting, retching or any combination thereof in a subject in need thereof, comprising coadministering to said subject a first amount of a 5-HT3 antagonist and a second amount of a NARI, wherein the first and second amounts together comprise a therapeutically effective amount or are each present in a therapeutically effective amount. In addition, the method of the invention comprises administering a NARI alone.
    Type: Application
    Filed: May 14, 2004
    Publication date: December 16, 2004
    Applicant: Dynogen, Inc.
    Inventors: Steven B. Landau, Cheryl L. Miller, Karl B. Thor
  • Method of treating lower urinary tract disorders
    Publication number: 20040209869
    Abstract: The invention relates to a method of treating at least one symptom of a lower urinary tract disorder in a subject in need of treatment wherein the symptom is selected from the group consisting of urinary frequency, urinary urgency, urinary urge incontinence, nocturia and enuresis. The method comprises administering to a subject in need of treatment a therapeutically effective amount of a compound that has 5-HT3 receptor antagonist activity and NorAdrenaline Reuptake Inhibitor (NARI) activity.
    Type: Application
    Filed: April 2, 2004
    Publication date: October 21, 2004
    Applicant: Dynogen Pharmaceuticals, Inc.
    Inventors: Steven B. Landau, Cheryl L. Miller, Mathew O. Fraser
  • Method of treating nausea, vomiting, retching or any combination thereof
    Publication number: 20040147510
    Abstract: The invention relates to a method of treating nausea, vomiting, retching or any combination thereof in a subject in need of treatment. The method comprises administering to a subject in need of treatment a therapeutically effective amount of a compound that has 5-HT3 receptor antagonist activity and NorAdrenaline Reuptake Inhibitor (NARI) activity. The invention further relates to a method of treating nausea, vomiting, retching or any combination thereof in a subject in need thereof, comprising coadministering to said subject a first amount of a 5-HT3 antagonist and a second amount of a NARI, wherein the first and second amounts together comprise a therapeutically effective amount or are each present in a therapeutically effective amount. In addition, the method of the invention comprises administering a NARI alone.
    Type: Application
    Filed: January 13, 2004
    Publication date: July 29, 2004
    Applicant: Dynogen Pharmaceuticals, Inc.
    Inventors: Steven B. Landau, Cheryl L. Miller, Karl B. Thor